181 related articles for article (PubMed ID: 3512613)
1. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.
Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ
J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin and renal graft histology.
d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between renal allograft rejection and cyclosporine toxicity: a clinicopathological study.
Alexopoulos E; Leontsini M; Daniilidis M; Sakellariou G; Visvardis G; Papadimitriou M
Am J Kidney Dis; 1991 Jul; 18(1):108-15. PubMed ID: 2063842
[TBL] [Abstract][Full Text] [Related]
5. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
[TBL] [Abstract][Full Text] [Related]
7. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.
Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W
J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264
[TBL] [Abstract][Full Text] [Related]
8. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.
Verani RR; Flechner SM; Van Buren CT; Kahan BD
Am J Kidney Dis; 1984 Sep; 4(2):185-91. PubMed ID: 6383031
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
Fuggle SV; McWhinnie DL; Morris PJ
Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR
Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382
[TBL] [Abstract][Full Text] [Related]
11. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.
Klintmalm G; Bohman SO; Sundelin B; Wilczek H
Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
[TBL] [Abstract][Full Text] [Related]
13. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
Nizze H; Gokel JM; Lang W; Mihatsch MJ
Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
[TBL] [Abstract][Full Text] [Related]
14. Blood cyclosporin concentrations and renal allograft dysfunction.
Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
[TBL] [Abstract][Full Text] [Related]
15. Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft recipient. The differentiation of drug nephrotoxicity from rejection by phenotyping of cellular infiltrates.
Kolbeck PC; Scheinman JI; Sanfilippo F
Arch Pathol Lab Med; 1986 May; 110(5):389-93. PubMed ID: 3516116
[TBL] [Abstract][Full Text] [Related]
16. Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients.
Prischl F; Gremmel F; Schwabe M; Schindler J; Balcke P; Kopsa H; Pinter G; Schwarzmeier J; Zazgornik J
Nephron; 1989; 51(3):330-7. PubMed ID: 2645532
[TBL] [Abstract][Full Text] [Related]
17. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity.
Yilmaz S; Taskinen E; Paavonen T; Mennander A; Häyry P
Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245
[TBL] [Abstract][Full Text] [Related]
18. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
[TBL] [Abstract][Full Text] [Related]
19. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin.
Farnsworth A; Hall BM; Ng AB; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
Am J Surg Pathol; 1984 Apr; 8(4):243-52. PubMed ID: 6369996
[TBL] [Abstract][Full Text] [Related]
20. Glomerular thrombi in renal allografts associated with cyclosporin treatment.
Neild GH; Reuben R; Hartley RB; Cameron JS
J Clin Pathol; 1985 Mar; 38(3):253-8. PubMed ID: 3882763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
